Loading…
Loading…
DNA.TA (Dna Group (T.R.) Ltd) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
DNA.TA does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for DNA.TA and 80,000+ other tickers.
See exactly how DNA.TA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for DNA.TA and 80,000+ other tickers.
Dna Group (T.R.) Ltd, along with its subsidiaries, specializes in the innovation, production, and worldwide distribution of proprietary ultrasound technologies. These advanced systems are utilized to evaluate bone strength and density, as well as to detect and monitor calcium leakage associated with osteoporosis in both adult and pediatric patients. The company's offerings are employed by trained physicians, nurses, and operators within hospitals, clinics, pharmacies, and various other healthcare environments across Israel, North America, East Asia, and international markets. Beyond its core…
No recent news available.